The C-terminal tail of aquaporin-2 determines apical trafficking  by Kuwahara, Michio et al.
Kidney International, Vol. 68 (2005), pp. 1999–2009
The C-terminal tail of aquaporin-2 determines apical trafficking
MICHIO KUWAHARA, TOMOKI ASAI, YOSHIO TERADA, and SEI SASAKI
Department of Nephrology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
The C-terminal tail of aquaporin-2 determines apical
trafficking.
Background. Aquaporin-2 (AQP-2) proteins are mainly ex-
pressed at the apical region of the collecting duct cells. We pre-
viously reported three different mutations in the C-terminus
of AQP-2 that all-cause autosomal-dominant nephrogenic di-
abetes insipidus. When one of these mutant AQP-2s was ex-
pressed in Madin-Darby canine kidney (MDCK) cells, it was
mistargeted to the basolateral membrane, suggesting a critical
role of the C-terminal tail in the apical trafficking of AQP-2.
Methods. Portions of the AQP-2 C-terminal tail (residues 226-
271) were mutated by the polymerase chain reaction (PCR)
technique and inserted into the pcDNA3.1 vector. Constructs
were transfected into MDCK cells to examine the localization of
mutated AQP-2 proteins by immunofluorescence microscopy.
Cell surface expression was detected by biotinylation assay.
Results. The wild-type AQP-2 was localized at the apical
membrane, whereas mutants lacking residues 262-271 (the last
10 amino acids) were predominantly distributed in the endo-
plasmic reticulum. Deletion mutants of the initial (226-240del)
and middle (241-252del) portions of the C-terminal tail were
identified at the apical membrane, suggesting that residues 226-
252 have no involvement in apical targeting. An AQP-4–AQP-2
chimera in which a portion of the AQP-4 C-terminal tail was re-
placed by the corresponding site in AQP-2 (residues 256-271)
was found at the apical membrane. The sequence of the last
4 amino acids of AQP-2 (G-T-K-A) corresponds to a PDZ-
interacting motif. Our investigations identified a mutant of this
portion mostly localized to the subapical region. Further, apical
expression was found to be significantly decreased in mutants
lacking a consensus sequence for cyclic adenosine monophos-
phate (cAMP)–dependent phosphorylation (residues 253-256).
Conclusion. The sequence at 256-271 is sufficient for apical
trafficking in AQP-2. The putative PDZ-interacting motif (G-
T-K-A, residues 268-271) plays a key role in apical membrane
expression. In addition, cAMP-dependent phosphorylation was
found to be critical for apical targeting.
Water movement across the cell membrane is an es-
sential process in the maintenance of cellular homeosta-
sis. Water molecules move through the aquaporin (AQP)
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water channels, a family of selective pores that belong
to the major intrinsic protein (MIP) superfamily [1, 2].
Hydropathy analysis of the MIP superfamily predicts six
transmembrane regions with N- and C-termini localized
in the cytoplasm. AQPs are found virtually in all species,
including more than ten kinds so far identified in mam-
mals [1, 3, 4]. Aquaporin-2 (AQP-2) is a vasopressin-
regulated water channel that plays a central role for the
urinary concentration from its sole site of expression in
the principal cells of the connecting tubule and collecting
duct cells [5, 6]. The binding of vasopressin to the V2 re-
ceptor on the basolateral membrane is generally thought
to activate cyclic adenosine monophosphate (cAMP)–
dependent protein kinase, a process that encourages cy-
toplasmic AQP-2–containing vesicles from the subapical
region to infiltrate the apical membrane, and thereby in-
crease its water permeability [7]. After the effect of vaso-
pressin subsides, AQP-2 channels are retrieved from the
apical membrane by endocytosis and the water perme-
ability returns to a low level.
In our previous report, we identified three mutations
of the AQP2 gene confirmed to cause the autosomal-
dominant form of nephrogenic diabetes insipidus (NDI)
[8]. All three of these mutations were localized to a sin-
gle allele in exon 4 of the AQP2 gene at the C-terminal
tail (721delG, 763-772del, and 812-818del). The wild-type
AQP-2 is a 271 amino acid protein, whereas these mu-
tant genes were predicted to encode 330-333 amino acid
proteins due to a frameshift mutation of the stop codon.
Our Xenopus oocyte expression study of these mutants
revealed an impairment in the trafficking to the plasma
membrane [8]. When one of these mutants (763-772del)
was expressed in polarized epithelia of Madin-Darby ca-
nine kidney (MDCK) cells, the mutant AQP-2 was mis-
targeted to the basolateral membrane, suggesting that the
AQP-2 C-terminus was responsible for apical targeting
[9]. Misrouting of C-terminal mutant AQP-2 has been
also reported in other cases of autosomal-dominant NDI
[10, 11]. These observations suggest that the C-terminal
tail of AQP-2 plays a critical role in apical trafficking.
The C-terminal tail of AQP-2 is composed of 46 amino
acid residues [5]. We hypothesized that a portions of
the residues in this sequence interact with proteins re-
sponsible for apical targeting. The AQP-2 C-terminal tail
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Table 1. C-terminal amino acid sequence of the wild-type and mutant AQP2s
AA 230 240 250 260 270
WT-AQP2 PAKSLSERLAVLKGLEPDTDWEEREVRRRQSVELHSPQSLPRGTKA
262-271del PAKSLSERLAVLKGLEPDTDWEEREVRRRQSVELHS
252-271del PAKSLSERLAVLKGLEPDTDWEEREV
242-271del PAKSLSERLAVLKGLE
232-271del PAKSLS
226-240del –——————————EPDTDWEEREVRRRQSVELHSPQSLPRGTKA
241-255del PAKSLSERLAVLKGL—–——————————SVELHSPQSLPRGTKA
241-252del PAKSLSERLAVLKGL-–————————–RRQSVELHSPQSLPRGTKA
269-271del PAKSLSERLAVLKGLEPDTDWEEREVRRRQSVELHSPQSLPRG
256-268del PAKSLSERLAVLKGLEPDTDWEEREVRRRQ—————————TKA
262-268del PAKSLSERLAVLKGLEPDTDWEEREVRRRQSVELHS—————TKA
S256A PAKSLSERLAVLKGLEPDTDWEEREVRRRQAVELHSPQSLPRGTKA
C-terminal tail of the wild-type (WT) AQP2 is composed of 46 amino acid (AA) residues, starting from P231 to A271.
contains several possible domains/motifs associated with
protein trafficking. Residues 253-256 (R-R-G-S) make up
a consensus sequence for cAMP-dependent protein ki-
nase (R-R-X-[S/T]) [5]. Indeed, cAMP-dependent phos-
phorylation was observed in wild-type AQP-2, but not in
S256A AQP-2 [12, 13]. Further, the plasma membrane
expression of AQP-2 was found to be inhibited in S256A
AQP-2 [13–16]. The final four amino acid sequence of
AQP-2 (G-T-K-A) corresponds to a class I PDZ domain
binding motif (X-[S/T]-X-). Similarly, residues 231-234
(S-E-R-L) comprise a class III PDZ-interacting motif
(-X-[D/E/K/R]-X-). Given that PDZ proteins are
known to tether membrane proteins [17, 18], these do-
mains may play a role in the apical distribution of AQP-2.
In the present study we transfected several AQP-2 mu-
tants in MDCK cells and identified their intracellular lo-
calization to determine the role of the AQP-2 C-terminus
in apical targeting.
METHODS
Preparation of cDNA and construction of mutants
Wild-type cDNA of human AQP-2 with a Kozak con-
sensus translation initiation site just upstream of the ini-
tial codon (ATG) was inserted into the pcDNA3.1 vector
(Invitrogen, CH Groningen, The Netherlands) between
the HindIII site and XbaI site [9]. To generate hemag-
glutinin (HA) epitope-tagged AQP-2, the nucleotide
sequence encoding the HA tag derived from human
hemagglutinin protein (YPYDVPDYA) was introduced
just after the initiation codon of AQP-2 cDNA. A method
of polymerase chain reaction (PCR)–based mutagene-
sis was used to construct a series of C-terminal mutants
of HA-tagged AQP-2 (Table 1), as described previ-
ously [9, 19]. The PCR products were digested with
HindIII and XbaI, and inserted into the pcDNA3.1 vec-
tor (Invitrogen). All of the mutations were confirmed
by a fluorescence DNA sequencer. In a separate ex-
periment, HA-tagged rat AQP-4 was cloned into the
pcDNA3.1 vector. A part of the AQP-4 C-terminal
tail (residues 285-323) (SQVETEDLILKPGVVHVI-
DIDRGDEKKGKDSSGEVLSSV) was replaced by
the corresponding site (residues 256-271) (SVELH-
SPQSLPRGTKA) from AQP-2 (AQP-4–AQP-2). A C-
terminal deletion mutant of AQP-4 (285-323del) was also
generated.
Cell culture and stable transfection
MDCK cells (Japanese Collection of Research Biolog-
icals #9029, Osaka, Japan) were cultured and transfected
stably with wild-type or mutant AQP-2 and AQP-4 us-
ing previously described methods [9]. Cells were grown
at 37◦C under a humidified atmosphere of 5% CO2.
Ten micrograms of the expression constructs of AQP-
2 were transfected into MDCK cells grown subconflu-
ently on dishes using the calcium-phosphate precipitation
technique. After 24 hours, the cells transfected with the
wild-type AQP-2 and mutant AQP-2 were trypsinized,
split among six dishes, and cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing 700 lg/mL of
G418 (Sigma Chemical Co., St. Louis, MO, USA). Ten to
14 days after the transfection, individual colonies were
selected using cloning rings and expanded. The clones
were isolated after the selection.
Confocal immunofluorescence microscopy
Transfected MDCK cells were grown on a perme-
able supported membrane (Transwell-Clear) (Corning,
Cambridge, MA, USA). After 3-day culture in DMEM,
confluent cells were incubated for 30 minutes with
DMEM containing 10−5 mol/L forskolin (Sigma Chem-
ical Co.) to induce apical expression of AQP-2. In
some protocols, cells were incubated for 30 minutes
with 0.5 mmol/L 8-(4-chlorophenylthio)-cAMP (Sigma
Chemical Co.). The cells were then fixed with 2%
paraformaldehyde in serum-free DMEM, washed with
phosphate-buffered saline (PBS), permeabilized with
0.2% Triton X-100 in PBS, blocked with 1% bovine
serum albumin (BSA) in PBS at 4◦C overnight, and
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stained [9]. Antibodies against the following proteins
were used to double stain the proteins in the trans-
fected cells: wild-type AQP-2 (rabbit or rat, an anti-
body against 15 C-terminal amino acids generated by
Sawady Technology) (Tokyo, Japan) (diluted 1:400);
HA peptide (rat) (1:200) (Roche Diagnostics, Penzberg,
Germany); Na-K-adenosine triphophatase (ATPase), a
basolateral membrane marker protein (mouse) (1:400)
(Upstate Biotechnology, Lake Placid, NY, USA); 78
kD glucose-regulated protein (GRP 78), an endoplas-
mic reticulum marker protein (rabbit) (1:200) (Stressgen,
Victoria, Canada); TGN 38, a trans-Golgi marker protein
(mouse) (1:200) (BD Biosciences, San Jose, CA, USA);
lysosome-associated membrane protein 1 (Lamp1), a late
endosomal/lysosomal marker protein (rabbit) (1:200)
(kindly provided by Dr. E. Kominami, Department of
Biochemistry, School of Medicine, Juntendo University);
and vesicle-associated membrane protein 2 (VAMP2),
a intracellular vesicle marker protein (rabbit) (1:200)
(Calbiochem, La Jolla, CA, USA).
After 1-hour incubation with a mixture of two antibod-
ies in PBS containing 1% BSA, the cells were washed with
PBS, further incubated with an antibody against rabbit
or rat IgG (1:200) (Alexa Fluor 488) (Molecular Probes,
Eugene, OR, USA) and rat or rabbit IgG (1:200) (Alexa
Fluor 568) (Molecular Probes) for 1 hour, washed again
with PBS and mounted in a mounting medium (Prolong
Antifade Kit) (Molecular Probes). In some protocols the
cells were pretreated with 100 mmol/L of trimethylamine-
N-oxide or 2% dimethyl sulfoxide (DMSO) as a chemical
chaperone for 4 hours just before the experiment. Im-
munofluorescent images were obtained with an LSM510
laser scanning confocal microscope system (Carl Zeiss,
Jena, Germany) using a 63× water-immersion objective.
Immunoblot analysis
The immunoblot analysis was performed as described
earlier [9]. Initially, the transfected cells were homog-
enized for 30 minutes in radioimmunoprecipitation as-
say (RIPA) buffer [50 mmol/L Tris-HCl, 150 mmol/L
NaCl, 1.0% NP-40, 0.5% deoxycholate, 0.1% sodium
dodecyl sulfate (SDS), pH 8.0] containing a protease
inhibitor cocktail (Boehringer Manheim, Manheim,
Germany). Next, the samples were centrifuged, dena-
tured and separated by SDS-polyacrylamide gel elec-
trophoresis (PAGE), and transferred to Immobilon-P
filters (Millipore, Bedford, MA, USA) using a semidry
system. Ten micrograms of total membrane protein was
loaded in each lane. The filters were examined by au-
toradiography after blocking, and two 1-hour incubations
with antibody against HA peptide and 125I-protein A so-
lution, respectively. Mock-transfected cells were treated
similarly to provide control. In one protocol, the sam-
ples were incubated with endoglycosidase H (Boehringer
Manheim) according to the manufacturer’s instructions.
The band intensities were calculated using NIH images to
compare the levels of protein expression quantitatively.
Four independent sets of experiments were performed in
each sample. Results were expressed as means ± SE in
arbitrary units and statistical significance was evaluated
by analysis of variance (ANOVA).
Cell surface biotinylation
Cells were seeded at a density of 1.5 × 105 cells/cm2
on a 12-well membrane support (1.0 cm2) (Transwell-
Clear) (Corning). After a 3-day culture in DMEM,
confluent cells were incubated for 30 minutes with
10−5 mol/L forskolin (Sigma Chemical Co.). Confluent
monolayer cells were washed twice with ice-cold PBS
containing 0.1 mmol/L CaCl2 + 1 mmol/L MgCl2 (PBS-
CM). All subsequent steps were essentially performed
at 4◦C. Sulfo-NHS-LC-Biotin (2 mg/mL) (Pierce, Rock-
ford, IL, USA) in biotinylation buffer (2 mmol/L CaCl2,
150 mmol/L NaCl, 10 mmol/L triethanol amine, pH 8.0)
was added to either the apical or basolateral compart-
ment of the filter chamber. Compartments not receiv-
ing Sulfo-NHS-LC-Biotin were filled with an equivalent
volume of biotinylation buffer alone. After 20 minutes
of incubation with gentle agitation, the cells were washed
with biotinylation buffer and the labeling procedure re-
peated. Unreacted Sulfo-NHS-LC-Biotin was quenched
by adding quenching buffer (100 mmol/L glycine in
PBS-CM). The cells were washed twice with ice-cold
PBS-CM and the filters were cut from the plastic sup-
port and incubated for 30 minutes at 37◦C with 1 mL
of lysis buffer [150 mmol/L NaCl, 50 mmol/L Tris-
HCl at pH 7.5, 5 mmol/L ethylenediaminetetraacetic
acid (EDTA), 1% NP-40, 0.1% SDS, 0.5% deoxy-
cholate) containing a protease inhibitor cocktail. The
cells were scraped from the filters, transferred to Ep-
pendorf tubes, and centrifuged at 14,000g for 5 minutes.
Next, 40 lL of streptavidin-agarose (Sigma Chemical
Co.), prepared by two washes with high salt buffer
(500 mmol/L NaCl, 5 mmol/L EDTA, 50 mmol/L Tris-
HCl, pH 7.5, 0.1% Triton-X) and two washes with lysis
buffer was added to the supernatant. After a 12-hour in-
cubation at 4◦C with end-over-end rotation, the beads
were centrifuged at 14,000g for 5 minutes and washed
twice with high-salt buffer, twice with lysis buffer, and
once with 10 mmol/L Tris-HCl, pH 7.5. After removing
the supernatant, the beads were resuspended in Laemmli
sample buffer and denatured for 30 minutes at 37◦C. Sub-
sequent procedures were essentially same as those used
for the immunoblots. Four to six independent experi-
ments were done and the band intensities obtained by
NIH images were expressed as means ± SE in arbitrary
units. Statistical significance was evaluated by ANOVA
or nonpaired t test.
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Fig. 1. Immunocytochemical localization of
the wild-type and mutant aquaporin-2 (AQP-
2) transfected in Madin-Darby canine kid-
ney (MDCK) cells. (A to C) Double staining
of the wild-type AQP-2 and Na-K-adenosine
triphosphatase (ATPase). The wild-type
AQP-2 was detected by an antibody against
15 C-terminal amino acids of AQP-2 (A)
and the HA-tagged wild-type AQP-2 was
detected by an antibody against HA pep-
tide after (B) and before (C) incubation
with forskolin. (D to H) Double staining
of the 262-271del and Na-K-ATPase (D),
78 kD glucose-related protein (GRP 78) af-
ter (E) and before (F) forskolin treatment,
trans-Golgi marker protein (TGN 38) (G),
and lysosome-associated membrane protein
1 (Lamp1) (H). (I and J) Double staining
of the 262-271del and Na-K-ATPase (I) and
GRP 78 (J) after pretreatment with a chem-
ical chaperone, trimethylamine-N-oxide. (K)
Double staining of Na-K-ATPase and the 226-
240del. (L to N) Double staining of the 241-
255del and Na-K-ATPase (L) and TGN 38
after (M) and before (N) the incubation with
forskolin. (O and P) Double staining of Na-
K-ATPase and the 241-252del after (O) and
before (P) the forskolin treatment. Cells were
viewed with a confocal microscope at 630×.
XY and YZ sections are shown in the upper
and lower panels, respectively (white bars in-
dicate 10 lm). HA, hemagglutinin.
RESULTS
Figure 1A shows the double staining of the wild-type
AQP-2 transfected in MDCK cells and a basolateral
membrane marker, Na-K-ATPase. An antibody against
the AQP-2 C-terminal detected AQP-2 proteins at the
apical membrane. Similarly, an antibody against HA iden-
tified the apical distribution of the HA-tagged wild-type
AQP-2 (Fig. 1B), suggesting that the insertion of the
HA tag had no inhibitory effects on the apical expres-
sion of the wild-type AQP-2. Based on this finding, we
used the anti-HA antibody to identify HA-tagged AQP-
2 mutants in subsequent protocols. Before treatment
with forskolin, the wild-type AQP-2 appeared to be dis-
tributed at the subapical region besides the apical mem-
brane (Fig. 1C). Thus forskolin further redistributed the
wild-type AQP-2 to the apical membrane. Similar find-
ings were observed when cells were incubated with 8-
(4-chlorophenylthio)-cAMP (not shown). These results
suggested that the stimulation of cAMP-dependent pro-
tein kinase enhanced apical AQP-2 trafficking. In con-
trast to the wild-type AQP-2, the 262-271del, an AQP-2
mutant lacking the last 10 amino acid residues, was lo-
calized in cytoplasm with a granular pattern (Fig. 1D).
Double staining of the 262-271del and 78 kD glucose-
regulated protein, an endoplasmic reticulum marker
protein, revealed a close colocalization irrespective of
forskolin treatment (Fig. 1E and F). On the other hand,
the distributions of the 262-271del proteins were not coin-
cident with that of TGN 38, a trans-Golgi marker protein
(Fig. 1G), and slightly overlapped with that of Lamp1,
a late endosomal/lysosomal marker protein (Fig. 1H).
The intracellular localizations of the 252-271del, 242-
271del, 232-271del were similar to that of the 262-271del
(not shown). On the basis of these results, we specu-
lated that AQP-2 mutants lacking the C-terminal 262-271
residues were basically retained in the endoplasmic retic-
ulum through the action of the endoplasmic reticulum
quality-control mechanisms. Preincubation with a chemi-
cal chaperone, trimethylamine-N-oxide, redistributed the
262-271del proteins mainly at the subapical area (Fig. 1I).
A small portion of the 262-271del proteins was colocal-
ized with TGN 38 in this condition (Fig. 1J). A similar
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Table 2. Apparent localization of the wild-type and mutant aquaporins (AQPs)
Localization of AQP protein after [F(+)]
Construct and before [F(−)] forskolin treatment Number of cell lines Number of cells
Wild-type AQP-2 Intracellular 3 35
262-271del F(+) apical, F(−) apical, subapical 4 30
252-271del F(+), F(−) subapical, apical 4 18
242-271del F(+) apical, F(−) apical, subapical 4 14
232-271del F(+), F(−) apical, subapical 3 15
226-240del F(+), F(−) apical, subapical 3 28
241-255del Intracellular 3 31
241-252del Intracellular 3 28
269-271AAA F(+), F(−) intracellular, apical 4 25
269-271del F(+) apical, F(−) apical, subapical 3 31
256-268del Intracellular 3 17
262-268del Intracellular 3 16
S256A F(+), F(−) intracellular, apical 4 30
AQP4-AQP2 F(+) apical, F(−) apical, subapical 3 27
Abbreviations are: F(+), apical; F(−), apical, subapical F(+); F(−), intracellular.
redistribution of the 262-271del was observed after in-
cubation with DMSO, another chemical chaperone (not
shown), suggesting that chemical chaperones may be able
to partially correct the retention of the mutant AQP-2
in the endoplasmic reticulum, as previously reported [20,
21]. In contrast to the truncation mutants, the 226-240del,
a mutant lacking the initial one third of the C-terminal
tail, was confined to the apical membrane area (Fig. 1K).
It thus appeared that the consensus sequences of the
class III PDZ domain (residues 231-234) play no part
in the apical targeting of AQP-2. The 226-240del was dis-
tributed apical and subapical region before incubation
with forskolin (not shown). Staining of the 241-255del,
the deletion of the middle portion of C-terminus was
identified at the subapical cytoplasm as well as the api-
cal membrane (Fig. 1L). Some of the 241-255del proteins
were colocalized with TGN 38 (Fig. 1M), suggesting that
the 241-255del was distributed at both the Golgi com-
plex and apical membrane. Localization of the 241-255del
seemed to be similar before and after incubation with
forskolin (Fig. 1M and N). In contrast, apical localiza-
tion was observed in the 241-252del (Fig. 1O), a mu-
tant in which a consensus sequence for cAMP-dependent
protein kinase is preserved. Forskolin as well as 8-(4-
chlorophenylthio)-cAMP apparently stimulated the api-
cal delivery of the 241-252del to some extent (Fig. 1O
and P). These findings had two implications: first, that
the sequence between 226 and 252 plays no part in apical
sorting, and second, that cAMP-dependent phosphoryla-
tion contributes to the translocation of AQP-2 from the
subapical region to the apical membrane. Table 2 sum-
marizes the apparent localization, the number of gener-
ated cell lines, and the number of cells examined in each
AQP-2 construct.
Next, we decided to perform a chimera study to make
up for the shortfall of meaningful results in the trunca-
tion studies due to the endoplamic reticulum retention.
AQP-4 proteins are known to exist at the basolateral
membrane of the principal cells in the collecting duct.
As expected, the wild-type AQP-4 transfected in MDCK
cell was expressed at the basolateral membrane (Fig. 2A).
Deletion of the last 39 amino acid residues of AQP-
4 (285-323del) did not change the basolateral expres-
sion (Fig. 2B). In contrast, AQP-4–AQP-2, a chimera in
which the last 16 amino acids of AQP-2 (residues 256-
271) were substituted for the corresponding site in the
AQP-4 C-terminal tail (residues 285-323), was localized
at the apical membrane (Fig. 2C). These results suggested
that the residues at 256-271play a critical role in the api-
cal trafficking. Forskolin appeared to stimulate the apical
trafficking of AQP-4–AQP-2 slightly (Fig. 2C and D). 8-
(4-chlorophenylthio)-cAMP had a similar effect on the
AQP-4–AQP-2 (not shown).
Our next endeavor was to examine the role of amino
acids at 256-271 in further detail. The last three amino
acids of AQP-2 were replaced by alanines (269-271AAA)
due to the compatibility of the sequence of the last four
amino acids of (G-T-K-A) with a PDZ-interacting do-
main. The 269-271AAA was apparently distributed at
the apical side (Fig. 3A), but not confined to the apical
membrane in the manner seen in the wild-type AQP-2
(Fig. 1A and B). The localization of the 269-271AAA
was similar even before the incubation with forskolin
(Fig. 3B), suggesting that forskolin had little effect on
the distribution of the 269-271AAA proteins. Double
staining of the 269-271AAA and intracellular organelle
markers showed that the 269-271AAA was rarely colo-
calized with 78 kD GRP, TGN 38, and Lamp1 (Fig. 3C
to E), but closely colocalized with VAMP2 (Fig. 3F).
The distribution of the mutant lacking the last three
amino acids of AQP-2 (269-271del) was similar to that
of the 269-271AAA (not shown). These observations
suggested that the putative PDZ-binding motif (residues
268-271) plays a critical role in trafficking from the intra-
cellular vesicles to the apical membrane. The other mu-
tants tested, namely, the 256-268del and 262-268del were
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Fig. 2. Immunocytochemical localization of
the wild-type and mutant aquaporin-4 (AQP-
4) doubly stained with Na-K-adenosine
triphosphatase (ATPase). (A) The wild-type
AQP-4. (B) 285-323del. The AQP-4 mutant
that lacks the last 39 amino acid residues. (C
and D) AQP-4–AQP-2. The AQP-4 chimera
(residues 1-284 in AQP-4) with the C-terminal
tail of AQP-2 (residues 256-271 in AQP-2) af-
ter (C) and before (D) the incubation with
forskolin. Cells were viewed with a confocal
microscope at 630×. XY and YZ sections are
shown in the upper and lower panels, respec-
tively (white bars indicate 10 lm).
Fig. 3. Immunocytochemistry of aquaporin-2 (AQP-2) and the basolateral membrane or intracellular organelle. (A to F) Double staining of the
269-271del and Na-K-adenosine triphophatase (ATPase) after (A) and before (B) the forskolin treatment, 78 kD glucose-related protein (GRP 78)
(C), trans-Golgi marker protein (TGN 38) (D), lysosome-associated membrane protein 1 (Lamp1) (E), and vesicle-associated membrane protein
2 (VAMP2) (F). (G to J) Double staining of the S256A and Na-K-ATPase after (G) and before (H) the incubation with forskolin, TGN 38 (I) and
VAMP2 (J). Cells were viewed with a confocal microscope at 630×. XY and YZ sections are shown in the upper and lower panels, respectively
(white bars indicate 10 lm).
predominantly coincident with 78 kD GRP (not shown).
Ser-256 is a site for cAMP-dependent phosphorylation
that regulates the exocytosis of AQP-2 [13, 14]. S256A,
the mutant of Ser-256, was apparently localized in both
the cytoplasm and apical region regardless of folkloric
treatment (Fig. 3G and H), as well as partially colocal-
ized with both TGN 38 (Fig. 3I) and VAMP2 (Fig. 3J).
We checked the synthesis of the AQP-2 proteins in
MDCK cells by immunoblot analysis using an antibody
against HA tag. The apparent molecular size of the wild-
type AQP-2 was 29 kD, and those of the mutant AQP-2
proteins were all close to the expected sizes (Fig. 4A).
An extra band was identified at a position approximately
3 kD higher than the original band in four AQP-2 mutants
lacking the last ten amino acid residues (262-271del, 252-
271del, 242-271del, and 232-271del), the 256-268del, and
the 262-268del. The extra band was digested after the
incubation with endoglycosidase H (Fig. 4B). Endogly-
cosidase H–sensitive glycoproteins are known to localize
in the endoplasmic reticulum [22]. In contrast, an addi-
tional band was not visible in four AQP-2s possessing the
final 16 amino acid tail (wild-type AQP-2, 226-240del,
241-255del, and S256A) and the 269-271del. To evaluate
the protein expression quantitatively, we calculated the
band intensities using NIH images. The band intensities
were 100 ± 31 (means ± SE in arbitrary units) in the
wild-type AQP-2 (N = 4), 117 ± 25 in the 226-240del
(N = 4), 128 ± 34 in the 241-255del (N = 4), 91 ± 28 in
the 269-271del (N = 4), and 82 ± 23 in the S256A (N = 4).
These values were not significantly different, suggesting
equivalent protein expression levels.
In our last experiment, we performed biotinylation as-
say to examine the cell surface expression of AQP. Ex-
pression at the apical membrane was detected in the wild-
type AQP-2, 226-240del, 241-255del, 269-271del, S256A
(Fig. 5A), wild-type AQP-2, AQP-4–AQP-2, and 241-
252del (Fig. 5B). Basolateral expression was observed
only in the wild-type AQP4 (Fig. 5A). In contrast, the
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Fig. 4. Immunoblot of membrane frac-
tions of the Madin-Darby canine kidney
(MDCK) cells transfected with the wild-
type aquaporin-2 (AQP-2) and C-terminal
AQP-2 mutants detected by an antibody
against HA peptide. (A) Lane 1, control
(mock-transfected cells); lane 2, the wild-type
AQP-2; lane 3, 262-271del; lane 4, 252-271del;
lane 5, 242-271del; lane 6, 232-271del; lane 7,
226-240del; lane 8, 241-255del; lane 9, 269-
271del; lane 10, 256-268del; lane 11, S261A;
and lane 12, 262-268del. Ten micrograms
of total membrane protein was loaded in
each lane. (B) Samples of the 262-271del,
252-271del, and 256-268del before (−) and
after (+) incubation with endoglycosidase H
(Endo). HA, hemagglutinin.
262-271del, 252-271del, and 256-268del proteins showed
no cell surface expression whatsoever (Fig. 5A). These re-
sults were consistent with the protein localization shown
in Figures 1 to 3. In Figure 5A series, the band intensities
of the wild-type AQP-2 (100 ± 27) (means ± SE in ar-
bitrary units) (N = 4) and 226-240del (85 ± 21) (N = 4)
were not significantly different (Fig. 5C). In contrast, the
apical expression was significantly decreased in the 241-
255del (28 ± 11) (N = 4) (P < 0.05), 269-271del (38 ±
12) (N = 4) (P < 0.05), and S256A (13 ± 6) (N = 4) (P <
0.05). In Figure 5B series, AQP-4–AQP-2 (35 ± 14) (N =
4) (P < 0.05) was significantly lower than the wild-type
AQP-2 (100 ± 22) (N = 4) and 241-252del (91 ± 17) (N =
4). We quantitatively determined the effect of forskolin
on the apical surface delivery of AQP proteins in the last
protocol (Fig. 5D). Forskolin significantly increased api-
cal expression of the wild-type AQP-2 (100 ± 15 to 208 ±
21) (N = 6) (P < 0.01), 241-252del (87 ± 14, to 193 ± 20)
(N = 6) (P < 0.01), 241-255del (39 ± 6 to 61 ± 8) (N = 6)
(P < 0.05), and AQP-4–AQP-2 (48 ± 7 to 76 ± 9) (N =
6) (P < 0.05) (Fig. 5E). In contrast, the effect of forskolin
was absent in the 269-271AAA (65 ± 11 to 71 ± 8)
(N = 6).
DISCUSSION
Previous reports suggested that the phosphorylation
of Ser-256 is a key signal for the plasma membrane tar-
geting of AQP-2 [13–16], and the S256A proteins were
distributed at the intracellular vesicles [15] or Golgi com-
plex [16], but basically absent in the apical membrane.
Similarly, our findings identified the partial expression
of S256A at the Golgi complex and intracellular vesicles
(Fig. 3). The apical expression of biotin-labeled S256A
was indeed identified, but the level of expression reached
only 13% of that of the wild-type AQP-2 (Fig. 5). A
low level of S256A expression at the apical surface is
consistent with recent evidence that another mechanism
independent of Ser-256 phosphorylation takes part in
AQP-2 apical trafficking. Studies in transfected LLC-
PK1 cells have suggested that AQP-2 is constitutively
recycled between the plasma membrane and intracellu-
lar vesicles in a vasopressin-independent manner [23].
This phosphorylation-independent apical trafficking of
AQP-2 has also been suggested by others [24–26]. We
performed cell surface biotinylation assay to examine the
effect of forskolin quantitatively. The apical expression of
the wild-type AQP-2 was increased by 108% in response
to forskolin (Fig. 5). The basal expression level before
forskolin treatment and the magnitude of stimulation by
forskolin were similar in the wild-type AQP-2 and 241-
252del, a mutant possessing the consensus sequence for
cAMP-dependent protein kinase. On the other hand, the
basal expression of the 241-255del and AQP-4–AQP-2
were significantly lower than that of the wild-type AQP-
2, reaching 39% and 48% of the latter level, respectively
(Fig. 5). The lack of the consensus sequence for cAMP-
dependent protein kinase (residues 253-256) might be re-
sponsible for the decrease in apical trafficking of these
proteins. Forskolin significantly increased apical deliv-
ery of the 241-255del and AQP-4–AQP-2 by 56% and
58%, respectively, suggesting the presence of the site
for cAMP-dependent phosphorylation in these proteins
(Fig. 5). However, the degree of forskolin-induced stim-
ulation was lower than that of the wild-type AQP-2 in
the 241-255del and AQP-4–AQP-2. We speculate from
these observations that the serine residue corresponding
to S256 in the wild-type AQP-2 is still cAMP-dependent
phosphorylation site and important for apical trafficking
in these proteins.
Our results on the AQP-4–AQP-2 chimera revealed
an important role of residues 256-271 in the apical ex-
pression of AQP-2 (Fig. 2). The basolateral trafficking in
AQP-4 is determined by a tyrosine-based motif (residues
277-280) and dileucine-based motif (residues 288-294)
at the C-terminal sequence [27]. A C-terminal deletion
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Fig. 5. Biotinylation of cell surface proteins. Confluent monolayers of transfected Madin-Darby canine kidney (MDCK) cells were incubated with
Sulfo-NHS-LC-Biotin and solubilized. Biotin-labeled proteins were separated from unlabeled proteins by adding streptavidin-agarose. Aquaporin
(AQP) proteins present in the pellet were detected by immunoblot using an antibody against HA peptide. Biotin was added either to the apical
(AP) or basolateral (BL) compartment of the filter chamber. (A) Lane 1, control (mock-transfected cells); lane 2, wild-type AQP-2; lane 3, wild-type
Kuwahara et al: Apical trafﬁcking of AQP-2 and C-terminus 2007
mutant of AQP-4 in this study (285-323del) was local-
ized at the basolateral membrane, probably because it
still possessed the tyrosine-based motif. Unexpectedly,
however, the addition of the AQP-2 C-terminal sequence
(residues 256-271) to 285-323del AQP-4 resulted in api-
cal expression of this chimera. It thus appeared that the
sequence at residues 256-271 in AQP-2 was sufficient for
apical trafficking and dominant over the basolateral sig-
nal of the tyrosine-based motif in AQP-4. In contrast to
our findings, a chimera protein of the transmembrane re-
gion of placental alkaline phosphatase with the AQP-2
C-terminal tail (residues 220-271) failed to express at the
apical membrane in an earlier study, suggesting that the
C-terminal sequence was not sufficient for apical expres-
sion [28]. Notwithstanding, this earlier chimeric protein
study did not rule out nonspecific processing defect be-
tween the endoplasmic reticulum and cell surface. The
chimera protein in our study was so carefully designed
that the corresponding sites of the C-terminal tail were
exchanged between AQP-2 and AQP-4. A recent study
examined the role of AQP-2 C-terminus by generating
chimeras of AQP-1 and AQP-2 [29]. AQP-1 with AQP-2
residues 220-271 showed apical localization, whereas
AQP-1s with AQP-2 residues distal to 230 were dis-
tributed at apical and basolateral membranes. This im-
plied that amino acids 220-229 are important for apical
sorting in AQP-2. While the present study found that
residues 226-229 were probably not responsible for apical
expression (226-240del) (Fig. 1), it did not examine the
significance of residues 220-225.
AQP-2 possesses a potential class I PDZ domain bind-
ing motif (X-S/T-X-) at the C-terminus (G-T-K-A)
(268-271). PDZ domains are ubiquitous protein-protein
interacting modules that recognize specific sequence mo-
tifs of transmembrane receptors, channels, and other
PDZ-containing proteins. Indeed, recent evidence sug-
gests that PDZ-interacting motifs mediate apical sort-
ing of numerous channels and transporters, including
cystic fibrosis transmembrane conductance regulator
(CFTR), Na/H exchanger regulatory factors (NHERFs),
c-aminobutyric acid transporter 3 (GAT-3), multidrug-
resistance-associated protein 2 (MRP2), and Na/Pi co-
transporter 1 and 2 (Npt1 and Npt2) [17, 18]. For example,
the last three amino acids at the C-terminus of the
CFTR (T-R-L) comprise a class I PDZ-interacting mo-
tif. The mistargeting of a mutant lacking this domain
(S1455X) to the basolateral membrane was found to lead
AQP-4; lane 4, 262-271del; lane 5, 252-271del; lane 6, 226-240del; lane 7, 241-255del; lane 8, 269-271del; lane 9, 256-268del; and lane 10, S256A. (B)
Lane 1, control; lane 2, wild-type AQP-2; lane 3, AQP-4–AQP-2; lane 4, 241-252del. (C) Summary of apical surface expression. ∗P < 0.05 compared
with wild-type AQP-2. (D) Effect of forskolin (FSK) on apical expression of AQP proteins. Cell surface biotinylation was assessed before (−) and
after (+) the incubation with forskolin. Lanes 1 and 2, control; lanes 3 and 4, wild-type AQP-2; lanes 5 and 6, 241-252del; lanes 7 and 8, 241-255del;
lanes 9 and 10, AQP-4–AQP-2; lanes 11and 12, 269-271AAA. (E) Summary of forskolin action on apical surface expression. ∗P < 0.05; ∗∗P < 0.01
compared with before pretreatment with forskolin. HA, hemagglutinin.
the pathogenesis of cystic fibrosis [30]. Interaction of
NHERF and ezrin-radixin-moesin-binding phosphopro-
tein 50 (EBP50), another PDZ protein, appears to regu-
late NHE3 through the protein kinase A pathway and
b-adrenergic receptor coupled pathway [31]. In the
present study, the 269-271AAA, a deletion mutant of a
putative AQP-2 PDZ ligand, was apparently distributed
in the subapical area irrespective of incubation with
forskolin (Fig. 3). Biotinylation analysis showed a de-
crease in the confirmable apical expression of the 269-
271AAA (34% of that of the wild-type AQP-2) (Fig. 5).
The 269-271AAA was mostly colocalized with intra-
cellular vesicles, with some additional staining in the
Golgi complex, late endosome/lysosome, and endoplas-
mic reticulum (Fig. 3). The signal-induced proliferation-
associated gene-1 (SPA-1) is a guanine triphosphatase
(GTPase)-activating protein (GAP) for Rap1 [32]. Our
group recently identified SPA-1 as a PDZ protein that
directly binds to the potential PDZ-interacting motif of
AQP-2 (residues 268-271) [33]. We showed that SPA-1
was colocalized with AQP-2 in the collecting duct and
that the GAP activity of SPA-1 was at least partially nec-
essary for the apical sorting of AQP-2. Now that the Rap1
GTPases may be critical regulators of vesicle trafficking
[34, 35], we speculated that the SPA-1 binding to AQP-2
reduces the levels of Rap1GTP that trigger F-actin dis-
assembly and thereby leads to an activation of AQP-2
exocytosis from the intracellular vesicles to the apical
membrane [33]. The retention of most of the AQP-2–
containing vesicles in the subapical compartment in the
present study was presumably due to the deletion of the
putative PDZ-interacting motif.
The apical localization of AQP-2 observed in this study
was consistent with previous transfection studies of AQP-
2 protein with MDCK cells [36, 37]. In contrast to MDCK
cells, AQP-2 transfected into LLC-PK1 cells was translo-
cated to the basolateral membrane upon vasopressin
stimulation [38]. It has been reported that LLC-PK1 cells
exhibit mislocalization to the apical membrane in sev-
eral proteins such as the low-density lipoprotein receptor
(LDLR), transferrin receptor (TfR), and H-K-APTase
beta subunit [39, 40]. The misrouting of LDLR and TfR
was due to the lack of the l1B subunit of AP-1B complex
because transfection of cDNA l1B into LLC-PK1 cells re-
stored the basolateral distribution of these proteins [39].
However, introduction of l1B failed to correct the baso-
lateral localization of AQP-2 and the apical localization
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of H-K-APTase beta subunit in LLC-PK1 cells [7, 40].
These findings suggested that the LLC-PK1 cells contain
another defect in sorting machinery besides the lack of
the l1B subunit. Recent evidence suggests that AQP-2
is expressed at the basolateral membrane of connecting
tubule (CNT) cells and inner medullary collecting duct
(IMCD) principal cells [6, 41–43]. Acute administration
of oxytocin redistributed cytoplasmic AQP-2 proteins to
the apical as well as the basolateral membrane in CNT
cells and IMCD principal cells of Sprague-Dawley rats
[42]. Moreover, 2-hour treatment with desamino-Cys1,
D-Arg8 vasopressin (dDAVP) markedly increased apical
expression of AQP-2 in CNT cells and IMCD principal
cells of Brattleboro rats [43]. These results suggested that
the stimulation of cAMP-dependent protein kinase ac-
celerates apical delivery of AQP-2 even in these cells.
The mechanisms underlying the basolateral targeting of
AQP-2 is unknown at present, although oxytocin and hy-
pertonicity were suggested to cause basolateral redistri-
bution of AQP-2 [42, 44]. Sorting mechanisms in CNT
cells and IMCD principal cells might be different from
those in cortical and outer medullary collecting duct prin-
cipal cells.
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